COVID-19 Pandemic Intensifying Opioid Crisis
AAPM member Halena Gazelka, MD was interviewed by ABC affiliate WXOW-TV in La Crosse, Wisconsin, regarding the effect of COVID-19 on pain patients and an increase in opioid-related deaths. Read more.
AAPM member Halena Gazelka, MD was interviewed by ABC affiliate WXOW-TV in La Crosse, Wisconsin, regarding the effect of COVID-19 on pain patients and an increase in opioid-related deaths. Read more.
A new cross-sectional study uncovers shortcomings in pivotal trials supporting new drug applications for opioid analgesics, which range from study design to duration. Read more.
This pilot RCT will examine the preliminary efficacy of a telehealth version of Mindfulness-Oriented Recovery Enhancement (MORE) enriched with a smartphone-based just-in-time adaptive intervention (JITAI) for patients with chronic pain on long-term opioid therapy. Read [...]
Intravenous (IV) ibuprofen adequately relieved acute pain and minimized opioid use in the first 48 hours after an orthopedic trauma, a trial in the Journal of Orthopaedic Trauma reported. Full story.
Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved QDOLO™ (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults for the management [...]
October 1, 2020, CHICAGO, Illinois – A multidisciplinary consensus panel convened by the American Academy of Pain Medicine Foundation has issued new recommendations in Mayo Clinic Proceedings about ensuring patient protections when tapering opioids. The [...]
Patients who need surgery to fix major bone fractures use fewer opioid pills after their procedure if they're reminded of six "core principles" that include: values, acceptance, present moment awareness, self-as-context, committed action, and diffusion. [...]
University of Wisconsin–Madison scientists have discovered that a majority of people they tested who were taking opioid painkillers for chronic back pain produced antibodies against the drugs that may contribute to some of the negative [...]
The U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and [...]
AAPM members Beth Darnall, PhD, and Mark Wallace, MD, were appointed to the Centers for Disease Control Opioid Workgroup by the Board of Scientific Counselors of the Centers for Disease Control and Prevention's National Center [...]